Source: SUNY Downstate Medical Center
Date: November 30, 2006
Summary:
Researchers at SUNY Downstate Medical Center have developed a substance that inhibits the progress of multiple sclerosis (MS) in an animal model. The agent, a novel calpain inhibitor, can be administered orally. In a paper published in the Journal of Neuroimmunology,researchers described the use of the calpain inhibitor for the treatment of a mouse model of MS. Whether administered by injection or by mouth, the inhibitor produced an almost complete cessation of the disease's progress.
No comments:
Post a Comment